Outcome and development of symptoms after orthotopic liver transplantation for Wilson disease

Clinical Transplantation

Volumn 27, Issue 6, 2013, Pages 914-922

  Weiss, Karl Heinz ^a   Schäfer, Mark ^a   Gotthardt, Daniel Nils ^a   Angerer, Alexandra ^a   Mogler, Carolin ^a   Schirmacher, Peter ^a   Schemmer, Peter ^a   Stremmel, Wolfgang ^a   Sauer, Peter ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

ATP7B; Copper; Neurologic deterioration; Orthotopic liver transplantation; Wilson's disease

Indexed keywords

AZATHIOPRINE; CERULOPLASMIN; COPPER; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; PENICILLAMINE; TACROLIMUS; TRIENTINE; ZINC;

ADULT; ARTICLE; ATP7B GENE; CAUSE OF DEATH; CERULOPLASMIN BLOOD LEVEL; CLINICAL ARTICLE; COPPER METABOLISM; DISEASE COURSE; FEMALE; FOLLOW UP; GENE; GENE MUTATION; GENOTYPE; GRAFT FAILURE; GRAFT SURVIVAL; HEART RIGHT VENTRICLE FAILURE; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LIVER FAILURE; LIVER FUNCTION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; MEDICAL RECORD REVIEW; NEUROLOGICAL COMPLICATION; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; REOPERATION; SCORING SYSTEM; SEPSIS; SURVIVAL RATE; SYMPTOM; TREATMENT OUTCOME; UNIFIED WILSON DISEASE RATING SCALE; WILSON DISEASE;

ATP7B; COPPER; NEUROLOGIC DETERIORATION; ORTHOTOPIC LIVER TRANSPLANTATION; WILSON'S DISEASE;

ADOLESCENT; ADULT; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEPATOLENTICULAR DEGENERATION; HUMANS; LIVER TRANSPLANTATION; NERVOUS SYSTEM DISEASES; NEUROPSYCHOLOGICAL TESTS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84889090429     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12259     Document Type: Article

References (52)

1. Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Wilson's disease. Lancet 2007: 369: 397.
2. Tanzi RE, Petrukhin K, Chernov I et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 1993: 5: 344.
3. Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 1993: 5: 327.
4. Roberts EA, Schilsky ML. A practice guideline on Wilson disease. Hepatology 2003: 37: 1475.
5. Ferenci P, Czlonkowska A, Merle U et al. Late-onset Wilson's disease. Gastroenterology 2007: 132: 1294.
6. Stremmel W, Meyerrose KW, Niederau C, Hefter H, Kreuzpaintner G, Strohmeyer G. Wilson disease: clinical presentation, treatment, and survival. Ann Intern Med 1991: 115: 720.
7. Merle U, Schaefer M, Ferenci P, Stremmel W. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut 2007: 56: 115.
8. Catana AM, Medici V. Liver transplantation for Wilson disease. World J Hepatol 2012: 4: 5.
9. Weiss KH, Gotthardt DN, Klemm D et al. Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease. Gastroenterology 2011: 140: 1189, e1181.
10. EASL Clinical Practice Guidelines. Wilson's disease. J Hepatol 2012: 56: 671.
11. Roberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: an update. Hepatology 2008: 47: 2089.
12. Dhawan A, Taylor RM, Cheeseman P, De Silva P, Katsiyiannakis L, Mieli-Vergani G. Wilson's disease in children: 37-year experience and revised King's score for liver transplantation. Liver Transpl 2005: 11: 441.
13. Nazer H, Ede RJ, Mowat AP, Williams R. Wilson's disease: clinical presentation and use of prognostic index. Gut 1986: 27: 1377.
14. Gaffney D, Fell GS, O'Reilly DS. ACP Best Practice No 163. Wilson's disease: acute and presymptomatic laboratory diagnosis and monitoring. J Clin Pathol 2000: 53: 807.
15. Petrasek J, Jirsa M, Sperl J et al. Revised King's College score for liver transplantation in adult patients with Wilson's disease. Liver Transpl 2007: 13: 55.
16. Gitlin JD. Wilson disease. Gastroenterology 2003: 125: 1868.
17. Weiss KH, Gotthardt D, Schmidt J et al. Liver transplantation for metabolic liver diseases in adults: indications and outcome. Nephrol Dial Transplant 2007: 22 (Suppl. 8): viii9.
18. Medici V, Mirante VG, Fassati LR et al. Liver transplantation for Wilson's disease: The burden of neurological and psychiatric disorders. Liver Transpl 2005: 11: 1056.
19. Schilsky ML, Scheinberg IH, Sternlieb I. Liver transplantation for Wilson's disease: indications and outcome. Hepatology 1994: 19: 583.
20. DuBois RS, Rodgerson DO, Martineau G et al. Orthotopic liver transplantation for Wilson's disease. Lancet 1971: 1: 505.
21. Emre S, Atillasoy EO, Ozdemir S et al. Orthotopic liver transplantation for Wilson's disease: a single-center experience. Transplantation 2001: 72: 1232.
22. Erol I, Alehan F, Ozcay F, Canan O, Haberal M. Neurological complications of liver transplantation in pediatric patients: a single center experience. Pediatr Transplant 2007: 11: 152.
23. Erol I, Alehan F, Ozcay F, Canan O, Haberal M. Neurologic complications of liver transplantation in pediatric patients with the hepatic form of Wilson's disease. J Child Neurol 2008: 23: 293.
24. Marin C, Robles R, Parrilla G, Ramirez P, Bueno FS, Parrilla P. Liver transplantation in Wilson's disease: are its indications established? Transpl Proc 2007: 39: 2300.
25. Schumacher G, Platz KP, Mueller AR et al. Liver transplantation in neurologic Wilson's disease. Transplant Proceed 2001: 33: 1518.
26. Lim KB, Schiano TD. Long-term outcome after liver transplantation. Mount Sinai J Med, New York 2012: 79: 169.
27. Asonuma K, Inomata Y, Kasahara M et al. Living related liver transplantation from heterozygote genetic carriers to children with Wilson's disease. Pediatr Transplant 1999: 3: 201.
28. Haberal M, Moray G, Karakayali H et al. Liver transplantation for Wilson's cirrhosis: one center's experience. Transpl Proc 1999: 31: 3160.
29. Wang XH, Cheng F, Zhang F et al. Living-related liver transplantation for Wilson's disease. Transplant Int: Official J European Soc Organ Transplant 2005: 18: 651.
30. Bax RT, Hassler A, Luck W et al. Cerebral manifestation of Wilson's disease successfully treated with liver transplantation. Neurology 1998: 51: 863.
31. Eghtesad B, Nezakatgoo N, Geraci LC et al. Liver transplantation for Wilson's disease: a single-center experience. Liver Transplant Surgery 1999: 5: 467.
32. Geissler I, Heinemann K, Rohm S, Hauss J, Lamesch P. Liver transplantation for hepatic and neurological Wilson's disease. Transpl Proc 2003: 35: 1445.
33. Mason AL, Marsh W, Alpers DH. Intractable neurological Wilson's disease treated with orthotopic liver transplantation. Dig Dis Sci 1993: 38: 1746.
34. Martin AP, Bartels M, Redlich J, Hauss J, Fangmann J. A single-center experience with liver transplantation for Wilson's disease. Clinical Transplant 2008: 22: 216.
35. Sevmis S, Karakayali H, Aliosmanoglu I et al. Liver transplantation for Wilson's disease. Transplant Proceed 2008: 40: 228.
36. Sutcliffe RP, Maguire DD, Muiesan P et al. Liver transplantation for Wilson's disease: long-term results and quality-of-life assessment. Transplantation 2003: 75: 1003.
37. Ferenci P, Caca K, Loudianos G et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int 2003: 23: 139.
38. Leinweber B, Moller JC, Scherag A et al. Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's disease. Movement Dis 2008: 23: 54.
39. Czlonkowska A, Tarnacka B, Moller JC et al. Unified Wilson's Disease Rating Scale - a proposal for the neurological scoring of Wilson's disease patients. Neurologia i neurochirurgia polska 2007: 41: 1.
40. Weiss KH, Merle U, Schaefer M, Ferenci P, Fullekrug J, Stremmel W. Copper toxicosis gene MURR1 is not changed in Wilson disease patients with normal blood ceruloplasmin levels. World J Gastroenterol 2006: 12: 2239.
41. Weiss KH, Runz H, Noe B et al. Genetic analysis of BIRC4/XIAP as a putative modifier gene of Wilson disease. J Inherit Metab Dis 2010: 33: 233.
42. Walshe JM. Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically. Ann Clin Biochem 2003: 40: 115.
43. Schiefermeier M, Kollegger H, Madl C et al. The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease. Brain: J Neurol 2000: 123 : 585.
44. Litwin T, Gromadzka G, Czlonkowska A. Gender differences in Wilson's disease. J Neurol Sci 2012: 312: 31.
45. Pfeiffenberger J, Gotthardt DN, Herrmann T et al. Iron metabolism and the role of HFE gene polymorphisms in Wilson disease. Liver Int 2012: 32: 165.
46. Weiss KH, Stremmel W. Evolving perspectives in Wilson disease: diagnosis, treatment and monitoring. Curr Gastroenterol Rep 2012: 14: 1.
47. Strand S, Hofmann WJ, Grambihler A et al. Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis. Nat Med 1998: 4: 588.
48. Shiraishi A, Hoshina T, Ihara K, Doi T, Ohga S, Hara T. Acute liver failure as the initial manifestation of Wilson disease triggered by human parvovirus b19 infection. Pediatr Infect Dis J 2012: 31: 103.
49. Welte S, Gagesch M, Weber A, Longerich T, Millonig G. Fulminant liver failure in Wilson's disease with histologic features of postinfantile giant cell hepatitis; cytomegalovirus as the trigger for both? Eur J Gastroenterol Hepatol 2012: 24: 328.
50. Bellary S, Hassanein T, Van Thiel DH. Liver transplantation for Wilson's disease. J Hepatol 1995: 23: 373.
51. Tamura S, Sugawara Y, Kishi Y, Akamatsu N, Kaneko J, Makuuchi M. Living-related liver transplantation for Wilson's disease. Clin Transplant 2005: 19: 483.
52. Walshe JM, Dixon AK. Dangers of non-compliance in Wilson's disease. Lancet 1986: 1: 845.